Sex Determining Region Y-Box 2 (SOX2) Is a Potential Cell-Lineage Gene Highly Expressed in the Pathogenesis of Squamous Cell Carcinomas of the Lung

• Ping Yuan ,

  Contributed equally to this work with: Ping Yuan, Humam Kadara

  Affiliation Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Humam Kadara ,

  Contributed equally to this work with: Ping Yuan, Humam Kadara

  Affiliation Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Carmen Behrens,

  Affiliation Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Ximing Tang,

  Affiliation Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Denise Woods,

  Affiliation Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Luisa M. Solis,

  Affiliation Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Jiaoti Huang,

  Affiliation Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, The University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Monica Spinola,

  Affiliation The Hamon Center for Therapeutic Oncology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Wenli Dong,

  Affiliation Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Guosheng Yin,

  Affiliation Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Junya Fujimoto,

  Affiliation Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Edward Kim,

  Affiliation Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Yang Xie,

  Affiliation Department of Biostatistics, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Luc Girard,

  Affiliation The Hamon Center for Therapeutic Oncology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Cesar Moran,

  Affiliation Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Waun Ki Hong,

  Affiliation Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• John D. Minna,

  Affiliations The Hamon Center for Therapeutic Oncology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
•  [ ... ],
• Ignacio I. Wistuba

  * E-mail: iiwistuba@mdanderson.org

  Affiliations Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• [ view all ]
• [ view less ]